C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

GlobeNewswire Inc. | Nov 5, 2026 7:00 AM EST

Cemsidomide Phase 2 MOMENTUM Trial On Track to Complete Enrollment in 1Q 2027 with Initial ORR Data Expected in 2H 2027